ENB-824

N/A

Report date: 2023/12/15 17:20:16
NME

Base Information

Drug NameENB-824
Drug Alias NameENB-824
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEngine Biosciences Pte Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A